Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NOVN crawled time : 22:13 save search
Novan Announces Closing of $5.95 Million Public Offering, including Partial Exercise of the Underwriter’s Option to Purchase Additional Securities
Published: 2020-03-03 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.0%
H: 1.32%
C: -2.7%
offering
Novan Announces Data from B-SIMPLE Week 24 Safety Evaluation and COVID-19 Business Updates
Published: 2020-03-23 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.22%
H: 36.07%
C: 12.75%
covid covid-19
Novan Announces $8.0 Million Registered Direct Offering Priced At-the-Market
Published: 2020-03-24 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -20.51%
H: 1.21%
C: -6.9%
offering
Novan Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market
Published: 2020-03-26 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 3.93%
H: 4.44%
C: 3.33%
offering
Novan Receives Verbal Guidance from FDA for SB206 and Announces Sato Program Advancement
Published: 2020-04-03 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 6.82%
H: 1.06%
C: -17.64%
fda program
Novan Announces Comprehensive Evaluation of Strategic and Financial Alternatives
Published: 2020-04-20 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -3.7%
H: 2.54%
C: -3.87%
Novan Announces Receipt of Written Minutes from Type C Meeting with FDA Regarding Development of SB206
Published: 2020-04-30 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -2.96%
H: 1.39%
C: -0.69%
fda
Novan to Present at Virtual Life Sciences Investor Forum on June 25
Published: 2020-06-24 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 1.94%
H: 0.43%
C: -9.17%
life science
Novan Anticipates Current Cash Position Provides Sufficient Capital to Conduct Additional SB206 Phase 3 Pivotal Trial
Published: 2020-06-25 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 8.88%
H: 1.33%
C: -14.96%
phase 3 trial positive
Novan to Host Live Audio Webcast of 2020 Annual Meeting of Stockholders
Published: 2020-07-23 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 4.41%
H: 1.15%
C: -8.45%
audio
Novan President and CEO, Paula Brown Stafford Named Chairman of the Board
Published: 2020-07-28 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -5.58%
H: 1.61%
C: -15.86%
ford ceo leo
Novan Initiates B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
Published: 2020-08-31 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 4.23%
H: 2.02%
C: -10.44%
phase 3 treatment
Novan Announces First Patient Enrolled and Dosed in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
Published: 2020-09-03 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 1.52%
H: 2.15%
C: -8.96%
phase 3 treatment enroll
Novan to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Published: 2020-09-09 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -0.52%
H: 12.08%
C: 9.21%
Novan Provides Pipeline and Priority Development Programs Update
Published: 2020-09-14 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 8.3%
H: 11.76%
C: 4.33%
program
Novan Strengthens Financial Leadership with Appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors
Published: 2020-09-24 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -2.09%
H: 0.54%
C: -4.71%
Novan’s NITRICIL™ Technology Shows In Vitro Antiviral Effect Against SARS-CoV-2 in Human Airway Infection Model
Published: 2020-10-14 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 61.52%
H: 0.94%
C: -23.15%
antiviral injection xin sars-cov-2 infections in vitro
Novan to Present at the Virtual Investor KOL Roundtable
Published: 2020-10-21 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -2.52%
H: 9.23%
C: 2.65%
presentation
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Published: 2020-10-30 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -0.15%
H: 2.32%
C: -2.95%
results
Novan Receives Approval to Transfer to Nasdaq Capital Market
Published: 2020-11-04 (Crawled : 22:13) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 5.93%
H: 1.54%
C: -6.48%
approval market nasdaq
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.